Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization.

Abstract:

:Many current experimental results show the necessity of new conceptual approaches to understand hematopoietic stem cell organization. Recently, we proposed a novel theoretical concept and a corresponding quantitative model based on microenvironment-dependent stem cell plasticity. The objective of our present work is to subject this model to an experimental test for the situation of chimeric hematopoiesis. Investigating clonal competition processes in DBA/2-C57BL/6 mouse chimeras, we observed biphasic chimerism development with initially increasing but long-term declining DBA/2 contribution. These experimental results were used to select the parameters of the mathematical model. To validate the model beyond this specific situation, we fixed the obtained parameter configuration to simulate further experimental settings comprising variations of transplanted DBA/2-C57BL/6 proportions, secondary transplantations, and perturbation of stabilized chimeras by cytokine and cytotoxic treatment. We show that the proposed model is able to consistently describe the situation of chimeric hematopoiesis. Our results strongly support the view that the relative growth advantage of strain-specific stem cells is not a fixed cellular property but is sensitively dependent on the actual state of the entire system. We conclude that hematopoietic stem cell organization should be understood as a flexible, self-organized rather than a fixed, preprogrammed process.

journal_name

Blood

journal_title

Blood

authors

Roeder I,Kamminga LM,Braesel K,Dontje B,de Haan G,Loeffler M

doi

10.1182/blood-2004-01-0282

subject

Has Abstract

pub_date

2005-01-15 00:00:00

pages

609-16

issue

2

eissn

0006-4971

issn

1528-0020

pii

2004-01-0282

journal_volume

105

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

    abstract::The zinc finger transcription factor GATA-2 is highly expressed in immature hematopoietic cells and declines with blood cell maturation. To investigate its role in normal adult hematopoiesis, a bicistronic retroviral vector encoding GATA-2 and the green fluorescent protein (GFP) was used to maintain the high levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Persons DA,Allay JA,Allay ER,Ashmun RA,Orlic D,Jane SM,Cunningham JM,Nienhuis AW

    更新日期:1999-01-15 00:00:00

  • GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

    abstract::Children with constitutional trisomy 21 (Down syndrome) have an approximately 500-fold increased risk of developing acute megakaryoblastic leukemia (AMKL), a form of acute myeloid leukemia. Unique to newborn infants with Down syndrome is a transient leukemia (TL), also referred to as transient myeloproliferative syndr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0013

    authors: Hitzler JK,Cheung J,Li Y,Scherer SW,Zipursky A

    更新日期:2003-06-01 00:00:00

  • Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation.

    abstract::Erythropoiesis is regulated at multiple levels to ensure the proper generation of mature red cells under multiple physiological conditions. To probe the contribution of long noncoding RNAs (lncRNAs) to this process, we examined >1 billion RNA-seq reads of polyadenylated and nonpolyadenylated RNA from differentiating m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-530683

    authors: Alvarez-Dominguez JR,Hu W,Yuan B,Shi J,Park SS,Gromatzky AA,van Oudenaarden A,Lodish HF

    更新日期:2014-01-23 00:00:00

  • Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

    abstract::Recent studies with long-term mouse marrow cultures have indicated the importance of the adherent layer as a primary reservoir of the most primitive stem cells, from which derivative stem cells and more differentiated progenitors are continuously generated. We have now examined the role of the adherent cell layer in l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulombel L,Eaves AC,Eaves CJ

    更新日期:1983-08-01 00:00:00

  • Mechanisms of anti-GPIbα antibody-induced thrombocytopenia in mice.

    abstract::Immune thrombocytopenia (ITP) is an acquired bleeding disorder characterized by antibody-mediated platelet destruction. Different mechanisms have been suggested to explain accelerated platelet clearance and impaired thrombopoiesis, but the pathophysiology of ITP has yet to be fully delineated. In this study, we tested...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003770

    authors: Morodomi Y,Kanaji S,Won E,Ruggeri ZM,Kanaji T

    更新日期:2020-06-18 00:00:00

  • A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo.

    abstract::Natural killer (NK) cells have been originally defined by their "naturally occurring" effector function. However, only a fraction of human NK cells is reactive toward a panel of prototypical tumor cell targets in vitro, both for the production of interferon-gamma (IFN-gamma) and for their cytotoxic response. In patien...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2007-11-122259

    authors: Guia S,Cognet C,de Beaucoudrey L,Tessmer MS,Jouanguy E,Berger C,Filipe-Santos O,Feinberg J,Camcioglu Y,Levy J,Al Jumaah S,Al-Hajjar S,Stephan JL,Fieschi C,Abel L,Brossay L,Casanova JL,Vivier E

    更新日期:2008-05-15 00:00:00

  • Morphologic and functional characteristics of bone marrow macrophages from imferon-treated mice.

    abstract::The iron storage macrophage has been isolated from the marrow of Imferon-treated mice and studied in vitro by morphologic, histochemical, and functional tests and isotope labeling techniques. These macrophages on stained preparations are large, many times binucleate cells (up to 150 mu), and show Prussian blue reactiv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fedorko ME

    更新日期:1975-03-01 00:00:00

  • High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.

    abstract::We have previously shown that intravenously injected peripheral blood (PB) or bone marrow (BM) cells from newly diagnosed chronic myeloid leukemia (CML) patients can engraft the BM of sublethally irradiated severe combined immunodeficient (SCID) mice. We now report engraftment results for chronic phase CML cells in no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wang JC,Lapidot T,Cashman JD,Doedens M,Addy L,Sutherland DR,Nayar R,Laraya P,Minden M,Keating A,Eaves AC,Eaves CJ,Dick JE

    更新日期:1998-04-01 00:00:00

  • Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells.

    abstract::Bortezomib is a proteasome inhibitor with remarkable preclinical and clinical antitumor activity in multiple myeloma (MM) patients. The initial rationale for its use in MM was inhibition of nuclear factor (NF)-kappaB activity by blocking proteasomal degradation of inhibitor of kappaBalpha (IkappaBalpha). Bortezomib in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-199604

    authors: Hideshima T,Ikeda H,Chauhan D,Okawa Y,Raje N,Podar K,Mitsiades C,Munshi NC,Richardson PG,Carrasco RD,Anderson KC

    更新日期:2009-07-30 00:00:00

  • Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

    abstract::Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-601187

    authors: Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

    更新日期:2015-05-07 00:00:00

  • Demonstration of reversible priming of human neutrophils using platelet-activating factor.

    abstract::Exposure of neutrophils to agents such as lipopolysaccharide, tumor necrosis factor-alpha (TNF-alpha), and the granulocyte-macrophage colony-stimulating factor causes a major upregulation of subsequent agonist-induced NADPH oxidase activation. This priming effect is a prerequisite for neutrophil-mediated tissue damage...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kitchen E,Rossi AG,Condliffe AM,Haslett C,Chilvers ER

    更新日期:1996-12-01 00:00:00

  • (Dicer)phering roles of microRNA in platelets.

    abstract::In this issue of Blood, Rowley et al report that noncoding RNAs precisely regulate the messenger RNA (mRNA) profile in platelets. Interfering in this process using genetically engineered mice affects hemostatic and thrombotic functions of platelets. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2016-01-694893

    authors: Boilard E,Belleannée C

    更新日期:2016-04-07 00:00:00

  • HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma.

    abstract::We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-590034

    authors: Zappasodi R,Ruggiero G,Guarnotta C,Tortoreto M,Tringali C,Cavanè A,Cabras AD,Castagnoli L,Venerando B,Zaffaroni N,Gianni AM,De Braud F,Tripodo C,Pupa SM,Di Nicola M

    更新日期:2015-03-12 00:00:00

  • Intrathymic progenitor cell transplantation across histocompatibility barriers results in the persistence of early thymic progenitors and T-cell differentiation.

    abstract::Donor hematopoietic stem cells (HSCs) can correct T-cell deficiencies in patients with severe combined immunodeficiency by replacing resident thymus cells. However, as those progenitors that naturally migrate to the thymus are not capable of supporting long-term thymopoiesis, a successful transplant is thought to requ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-08-447417

    authors: de Barros SC,Vicente R,Chebli K,Jacquet C,Zimmermann VS,Taylor N

    更新日期:2013-03-14 00:00:00

  • Neurologic complications after allogeneic marrow transplantation for sickle cell anemia.

    abstract::Seven of 21 patients with sickle cell anemia developed neurologic complications 5 to 243 days (median, 33 days) after allogeneic marrow transplantation. Among these 7 patients, indications for transplantation included either a past history of stroke (4 patients) or recurrent severe vaso-occlusive events (3 patients). ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Walters MC,Sullivan KM,Bernaudin F,Souillet G,Vannier JP,Johnson FL,Lenarsky C,Powars D,Bunin N,Ohene-Frempong K

    更新日期:1995-02-15 00:00:00

  • Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation.

    abstract::The subcellular localization of the platelet membrane receptors glycoproteins (GP) Ib and IIb/IIIa [corrected] has been studied within resting platelets by a combination of biochemical and cytochemical techniques. While both GPIb and GPIIb/IIIa are localized within the plasma membrane and surface-connected canalicular...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cramer EM,Lu H,Caen JP,Soria C,Berndt MC,Tenza D

    更新日期:1991-02-15 00:00:00

  • Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. The Benelux CML Study Group.

    abstract::Interferon-alpha (IFN-alpha) is considered the standard therapy for chronic myeloid leukemia (CML) patients not suitable for allogeneic stem cell transplantation. From 1987 through 1992, 195 patients in the Benelux with recent untreated CML were randomized between low-dose IFN-alpha2b (3 MIU, 5 days/wk) or hydroxyurea...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors:

    更新日期:1998-04-15 00:00:00

  • Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

    abstract::Activated protein C is a potent anticoagulant and profibrinolytic enzyme that can be derived from the vitamin-K-dependent serine protease zymogen, protein C, by the action of thrombin. Protein C antigen concentration was determined in plasmas from normals (n = 40) and from 38 patients with intravascular coagulation as...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Griffin JH,Mosher DF,Zimmerman TS,Kleiss AJ

    更新日期:1982-07-01 00:00:00

  • Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.

    abstract::Peripheral blood mononuclear cells (PBMC) from 17 patients receiving HLA-identical sibling bone marrow grafts were stimulated with host pretransplant PBMC. Cytotoxic T-cell lines (TCL) with specificity for host pretransplant PBMC were obtained from 9 of these patients, all presenting with severe graft-versus-host dise...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Niederwieser D,Grassegger A,Auböck J,Herold M,Nachbaur D,Rosenmayr A,Gächter A,Nussbaumer W,Gaggl S,Ritter M

    更新日期:1993-04-15 00:00:00

  • Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

    abstract::CD4+CD25+ regulatory T (Treg) cells are potent modulators of alloimmune responses. In murine models of allogeneic bone marrow transplantation, adoptive transfer of donor CD4+CD25+ Treg cells protects recipient mice from lethal acute graft-versus-host disease (aGVHD) induced by donor CD4+CD25- T cells. Here we examined...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-2044

    authors: Ermann J,Hoffmann P,Edinger M,Dutt S,Blankenberg FG,Higgins JP,Negrin RS,Fathman CG,Strober S

    更新日期:2005-03-01 00:00:00

  • The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.

    abstract::A plethora of myeloma growth factors (MGFs) has been identified, but their relative importance and cooperation have not been determined. We investigated 5 MGFs (interleukin-6 [IL-6], insulin-like growth factor type 1 [IGF-1], hepatocyte growth factor [HGF], HB-epidermal growth factor [HB-EGF], and a proliferation-indu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170464

    authors: Sprynski AC,Hose D,Caillot L,Réme T,Shaughnessy JD Jr,Barlogie B,Seckinger A,Moreaux J,Hundemer M,Jourdan M,Meissner T,Jauch A,Mahtouk K,Kassambara A,Bertsch U,Rossi JF,Goldschmidt H,Klein B

    更新日期:2009-05-07 00:00:00

  • Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha.

    abstract::We describe a patient with the so-called "prolymphocytic variant" form of hairy cell leukemia (HCL) resistant to treatment with interferon-alpha (IFN-alpha). Analysis of immunoglobulin (Ig) and T-cell receptor-beta (TCR beta) gene rearrangements from serial peripheral blood mononuclear cell specimens (MNCs) confirmed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Giardina SL,Young HA,Faltynek CR,Jaffe ES,Clark JW,Steis RG,Urba WJ,Mathieson BJ,Gralnick H,Lawrence J

    更新日期:1988-11-01 00:00:00

  • Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is a severe renal disease that is associated with defective complement regulation caused by multiple factors. We previously described the deficiency of factor H-related proteins CFHR1 and CFHR3 as predisposing factor for aHUS. Here we identify in an extended cohort of 147 aHUS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-109876

    authors: Józsi M,Licht C,Strobel S,Zipfel SL,Richter H,Heinen S,Zipfel PF,Skerka C

    更新日期:2008-02-01 00:00:00

  • CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.

    abstract::Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population that shares certain characteristics including an aberrant myeloid phenotype and the ability to suppress T cells. MDSCs have been predominantly studied in malignant diseases and findings suggest involvement in tumor-associated immune suppress...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2013-12-546416

    authors: Jitschin R,Braun M,Büttner M,Dettmer-Wilde K,Bricks J,Berger J,Eckart MJ,Krause SW,Oefner PJ,Le Blanc K,Mackensen A,Mougiakakos D

    更新日期:2014-07-31 00:00:00

  • Transformation of Fanconi's anemia to acute nonlymphocytic leukemia associated with emergence of monosomy 7.

    abstract::Two sisters in whom a diagnosis of Fanconi's anemia was made at ages 12 and 18 subsequently developed acute nonlymphocytic leukemia (ANLL). A third sibling had previously died at age 11 of apparent sepsis. Both sisters had cytogenetic studies that showed increased chromosomal breakage and a 46,XX karyotype, but subseq...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stivrins TJ,Davis RB,Sanger W,Fritz J,Purtilo DT

    更新日期:1984-07-01 00:00:00

  • Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness.

    abstract::Hematopoietic stem cell (HSC) transplantation is a lifesaving therapy for malignant and nonmalignant hematologic diseases and metabolic disorders. Although successful, hematopoietic transplantation can be hindered by inadequate stem cell number or poor engrafting efficiency. To overcome these deficits, we and others h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-07-515288

    authors: Hoggatt J,Mohammad KS,Singh P,Pelus LM

    更新日期:2013-10-24 00:00:00

  • Reversing anti-factor Xa agents and the unmet needs in trauma patients.

    abstract::Andexanet alfa, a reversing agent for anticoagulants that inhibit factor Xa, has recently been licensed in the United States. We discuss the impact of this licensure on current practice and review in detail the problems of a neglected and growing clinical area: reversing the anticoagulation effect of factor Xa inhibit...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-850396

    authors: Hunt BJ,Neal MD,Stensballe J

    更新日期:2018-12-06 00:00:00

  • Cell interactions influencing murine marrow megakaryocytes: nature of the potentiator cell in bone marrow.

    abstract::Auxiliary bone marrow cells are required for optimal murine megakaryocyte colony formation in addition to progenitor cells and a colony stimulating activity (CSA) present in WEHI-3 cell conditioned medium. These auxiliary cells are adherent, with a sedimentation rate of 5.8 mm hr-1 and buoyant density of 1.065-1.078 g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Williams N,Jackson H,Ralph P,Nakoinz I

    更新日期:1981-01-01 00:00:00

  • Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.

    abstract::Recently (J Pharmacol Exp Ther 261:580, 1992), we have shown that K562 leukemia cells express a calcium-signaling purinoceptor with characteristics of the P2T receptor subtype for adenosine diphosphate (ADP) previously found only in platelets. Because these results suggested that the P2T receptor may be an early marke...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Murgo AJ,Contrera JG,Sistare FD

    更新日期:1994-03-01 00:00:00

  • Ibrutinib: a force with a dark side?

    abstract::In this issue of Blood, Martin et al report poor outcomes for ibrutinib-refractory patients with mantle cell lymphoma (MCL). MCL, an uncommon B-cell lymphoma driven by dysregulated cyclin D1, responds well to initial therapy but is destined to relapse. Subsequent single-agent treatments had modest response rates and d...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2016-02-694877

    authors: Smith MR

    更新日期:2016-03-24 00:00:00